Linden Thomas Advisory Services, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Linden Thomas Advisory Services, LLC

  • $789 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
SELL
$37.35 - $52.15 $2,465 - $3,441
-66 Reduced 1.06%
6,172 $285 Million
Q1 2023

Apr 24, 2023
BUY
$36.99 - $48.71 $18,125 - $23,867
490 Added 8.52%
6,238 $250 Million
Q4 2022

Feb 16, 2023
BUY
$33.72 - $46.33 $193,822 - $266,304
5,748 New
5,748 $266 Million

Others Institutions Holding RARE

# of Institutions
326
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email